CH623326A5 - - Google Patents

Download PDF

Info

Publication number
CH623326A5
CH623326A5 CH1523375A CH1523375A CH623326A5 CH 623326 A5 CH623326 A5 CH 623326A5 CH 1523375 A CH1523375 A CH 1523375A CH 1523375 A CH1523375 A CH 1523375A CH 623326 A5 CH623326 A5 CH 623326A5
Authority
CH
Switzerland
Prior art keywords
parts
weight
oxo
imidazolidine
sodium
Prior art date
Application number
CH1523375A
Other languages
German (de)
English (en)
Inventor
Hans-Bodo Dr Koenig
Karl Georg Dr Metzger
Michael Dr Preiss
Wilfried Dr Schroeck
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742456307 external-priority patent/DE2456307A1/de
Priority claimed from DE19752512998 external-priority patent/DE2512998A1/de
Priority claimed from DE19752525541 external-priority patent/DE2525541C2/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CH623326A5 publication Critical patent/CH623326A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1523375A 1974-11-28 1975-11-24 CH623326A5 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19742456307 DE2456307A1 (de) 1974-11-28 1974-11-28 Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19752512998 DE2512998A1 (de) 1975-03-25 1975-03-25 Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19752525541 DE2525541C2 (de) 1975-06-07 1975-06-07 β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH623326A5 true CH623326A5 (fr) 1981-05-29

Family

ID=27186174

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1523375A CH623326A5 (fr) 1974-11-28 1975-11-24

Country Status (22)

Country Link
US (1) US4147693A (fr)
JP (2) JPS5182286A (fr)
AR (1) AR210103A1 (fr)
AT (1) AT342196B (fr)
AU (1) AU499337B2 (fr)
CA (1) CA1064020A (fr)
CH (1) CH623326A5 (fr)
DD (1) DD124736A5 (fr)
DK (1) DK535675A (fr)
ES (1) ES443008A1 (fr)
FI (1) FI66004C (fr)
FR (1) FR2292471A1 (fr)
GB (1) GB1486349A (fr)
HK (1) HK19678A (fr)
IE (1) IE43813B1 (fr)
IL (1) IL48538A (fr)
LU (1) LU73873A1 (fr)
NL (1) NL7513746A (fr)
NO (1) NO753818L (fr)
NZ (1) NZ179347A (fr)
RO (1) RO68146A (fr)
SE (1) SE434513B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061861A (en) * 1976-06-21 1977-12-06 Eli Lilly And Company 7-[α-(2,3-DIHYDRO-2-OXO-1H-benzimidazol-1-ylcarbonyl-amino)arylacetamido]cephalosporins
JPS5326143A (en) * 1976-08-24 1978-03-10 Oki Electric Ind Co Ltd Coupling method for op tical fiber
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
GB1584400A (en) * 1976-12-24 1981-02-11 Bayer Ag (2-oxo-imidazoliden-1-yl(carbonylamino)-acetamido-cephalosporins and penicillins
DE2732283A1 (de) * 1977-07-16 1979-01-25 Bayer Ag Beta-lactam-verbindungen
JPS5616489A (en) * 1979-07-20 1981-02-17 Ajinomoto Co Inc Imidazolecarboxylic acid derivative
US4386199A (en) * 1980-01-03 1983-05-31 E. R. Squibb & Sons, Inc. Cephalosporins having an imino substituted piperazindioncarbonylamino acyl sidechain
US4436904A (en) * 1981-02-14 1984-03-13 Kanto Ishi Pharmaceutical Co., Ltd. Cephalosporins
GB8318846D0 (en) * 1983-07-12 1983-08-10 Fujisawa Pharmaceutical Co Prophylactic/therapeutic agent against fish diseases
CN103360321B (zh) * 2012-04-05 2016-09-21 北京勤邦生物技术有限公司 呋喃妥因代谢物半抗原及其制备方法和应用
CN111995663B (zh) * 2020-09-02 2023-07-28 重庆大学 一种含有N-氨基咪唑烷-2-酮结构的Ang-（1-7）多肽类似物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939149A (en) * 1970-05-25 1976-02-17 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3980792A (en) * 1970-05-25 1976-09-14 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3974140A (en) * 1970-05-25 1976-08-10 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
CH571524A5 (fr) * 1970-05-25 1976-01-15 Bayer Ag
CH562249A5 (fr) * 1970-05-25 1975-05-30 Bayer Ag
US3732332A (en) * 1970-10-16 1973-05-08 Allied Chem Production of low molecular weight polyanhydrides and epoxy compositions derived therefrom
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
BE790441A (fr) * 1971-10-23 1973-04-24 Bayer Ag Nouvelles penicillines, leur procede de preparation et medicament les contenant
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
DE2354219A1 (de) * 1973-10-30 1975-05-07 Bayer Ag Beta-lactam-antibiotica, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
FI66004B (fi) 1984-04-30
CA1064020A (fr) 1979-10-09
AT342196B (de) 1978-03-28
ATA907275A (de) 1977-07-15
AU8708575A (en) 1977-06-02
DK535675A (da) 1976-05-29
IE43813L (en) 1976-05-28
HK19678A (en) 1978-04-20
IE43813B1 (en) 1981-06-03
GB1486349A (en) 1977-09-21
JPS6043332B2 (ja) 1985-09-27
NO753818L (fr) 1976-05-31
RO68146A (fr) 1980-04-15
AR210103A1 (es) 1977-06-30
JPS5182286A (en) 1976-07-19
LU73873A1 (fr) 1976-09-06
ES443008A1 (es) 1977-05-01
IL48538A0 (en) 1976-01-30
JPS6114151B2 (fr) 1986-04-17
JPS5176438A (fr) 1976-07-02
NL7513746A (nl) 1976-06-01
IL48538A (en) 1979-07-25
NZ179347A (en) 1978-04-28
FI66004C (fi) 1984-08-10
FR2292471B1 (fr) 1981-12-31
FR2292471A1 (fr) 1976-06-25
SE434513B (sv) 1984-07-30
SE7513378L (sv) 1976-05-31
US4147693A (en) 1979-04-03
FI753333A (fr) 1976-05-29
DD124736A5 (fr) 1977-03-09
AU499337B2 (en) 1979-04-12

Similar Documents

Publication Publication Date Title
EP0049448B1 (fr) Antibiotiques bêta-lactame, leur préparation et compositions les contenant
CH623326A5 (fr)
DE2407715C2 (de) Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
EP0004956A1 (fr) Antibiotiques du type bêta-lactame, leur procédé de préparation, additifs pour nourriture de bétail, médicaments et leur procédé de préparation
EP0000392B1 (fr) Céphalosporines et pénicillines, procédés pour leur préparation et leurs compositions pharmaceutiques
CH633802A5 (de) Verfahren zur herstellung neuer beta-lactam-antibiotica.
DE2354219A1 (de) Beta-lactam-antibiotica, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0092722B1 (fr) Antibiotiques bêta-lactamiques, procédé pour leur préparation ainsi que leur utilisation comme médicaments
EP0000380A1 (fr) Pénicillines, procédé pour leur préparation et leur application
DE2456307A1 (de) Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2720579A1 (de) Beta-lactam-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2633317A1 (de) Beta-lactamantibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2440268A1 (de) Beta-lactamantibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2810083A1 (de) Beta-lactam-verbindungen
DE2528079A1 (de) Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658718A1 (de) Methoxy-beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2727586A1 (de) Methoxy-beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung
DE2720580A1 (de) Beta-lactam-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658905A1 (de) Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2525541A1 (de) Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2512998A1 (de) Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH628056A5 (en) Process for the preparation of beta-lactam antibiotics
DE2658906A1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2528078A1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0000393A1 (fr) Composés bêta-lactames, procédé pour leur préparation et leur utilisation

Legal Events

Date Code Title Description
PL Patent ceased